AI assistant
PULSE BIOSCIENCES, INC. — Director's Dealing 2025
Sep 16, 2025
32093_dirs_2025-09-15_76b9d6d5-e468-4855-b41a-f4f76f9ead8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2025-09-11
Reporting Person: UECKER DARRIN (Director, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-11 | Common Stock | M | 25000 | $4 | Acquired | 147872 | Direct |
| 2025-09-11 | Common Stock | S | 25000 | $14.78 | Disposed | 122872 | Direct |
| 2025-09-12 | Common Stock | M | 25000 | $4 | Acquired | 147872 | Direct |
| 2025-09-12 | Common Stock | S | 25000 | $14.32 | Disposed | 122872 | Direct |
| 2025-09-15 | Common Stock | M | 25000 | $4 | Acquired | 147872 | Direct |
| 2025-09-15 | Common Stock | S | 25000 | $15.77 | Disposed | 122872 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-09-11 | Stock Option (right to buy) | $4 | M | 25000 | Disposed | 2025-09-20 | Common Stock (25000) | Direct |
| 2025-09-12 | Stock Option (right to buy) | $4 | M | 25000 | Disposed | 2025-09-20 | Common Stock (25000) | Direct |
| 2025-09-15 | Stock Option (right to buy) | $4 | M | 25000 | Disposed | 2025-09-20 | Common Stock (25000) | Direct |
Footnotes
F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025.
F2: The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $14.41 to $15.14 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
F3: The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $13.80 to $14.76 per share.
F4: The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.18 to $17.20 per share.
F5: Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015.